MitraClip as a therapeutic strategy for post-myocardial infarction mitral regurgitation

J Cardiothorac Surg. 2023 Feb 2;18(1):55. doi: 10.1186/s13019-023-02165-w.

Abstract

Mitral regurgitation is a serious complication of post-myocardial infarction, with increasing mortality. Surgery as the primary treatment carries a high risk. MitraClip is a new therapeutic to treat post-myocardial infarction mitral regurgitation. In this case, a 62-year-old male patient suffered from severe heart failure symptoms after emergency coronary intervention and extracorporeal membrane oxygenation support. Based on cardiac echocardiography, severe mitral regurgitation was monitored in this patient. After MitraClip treatment, the patient's condition was gradually improved and discharged successfully. This case highlights that MitraClip is a safe and effective strategy for post-myocardial infarction mitral regurgitation.

Keywords: Acute myocardial infarction; Case report; Edge-to-edge repair; MitraClip; Mitral regurgitation.

Publication types

  • Case Reports

MeSH terms

  • Heart Valve Prosthesis Implantation* / adverse effects
  • Humans
  • Male
  • Middle Aged
  • Mitral Valve / surgery
  • Mitral Valve Insufficiency* / diagnosis
  • Mitral Valve Insufficiency* / etiology
  • Mitral Valve Insufficiency* / surgery
  • Myocardial Infarction* / complications
  • Myocardial Infarction* / diagnosis
  • Myocardial Infarction* / surgery
  • Treatment Outcome